株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

迷走神経刺激装置市場: 市場機会分析および将来予測

Vagus Nerve Stimulators Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

発行 Coherent Market Insights 商品コード 817575
出版日 ページ情報 英文 157 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.53円で換算しております。
Back to Top
迷走神経刺激装置市場: 市場機会分析および将来予測 Vagus Nerve Stimulators Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
出版日: 2019年02月28日 ページ情報: 英文 157 Pages
概要

当レポートでは、迷走神経刺激装置の世界市場を調査し、市場の概要、タイプ、用途、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の概要

  • レポートの説明
  • 市場の定義と範囲
  • エグゼクティブサマリー
  • 市場スニペット:製品タイプ別
  • 市場スニペット:用途別
  • 市場スニペット:流通チャネル別
  • 市場スニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場のダイナミクス、規制、動向分析

  • マーケットダイナミクス
  • 成長要因
  • 阻害要因
  • 市場機会
  • 影響分析
  • 新製品の発売/承認
  • PEST分析
  • ファイブフォース分析
  • 返済シナリオ

第4章 迷走神経刺激装置市場:製品タイプ別

  • イントロダクション
  • 市場シェア分析、2018年・2026年(%)
  • 成長分析、2017年-2026年
  • セグメント動向
  • 植込み型機器
  • 外部機器

第5章 迷走神経刺激装置市場:用途別

  • イントロダクション
  • 市場シェア分析、2018年・2026年(%)
  • 成長分析、2017年-2026年
  • セグメント動向
  • てんかん
  • うつ病
  • 群発性頭痛および片頭痛
  • その他

第6章 迷走神経刺激装置市場:流通チャネル別

  • イントロダクション
  • 市場シェア分析、2018年・2026年(%)
  • 成長分析、2017年-2026年
  • セグメント動向
  • 病院
  • 専門薬局
  • その他

第7章 迷走神経刺激装置市場:地域別

  • イントロダクション
  • 市場シェア分析:地域別、2018年・2026年(%)
  • 地域別、2017年 - 2026年の成長分析
  • 北米
  • 欧州
  • アジア太平洋
  • 中南米
  • アフリカ
  • 中東

第8章 競争環境

  • ヒートマップ解析
  • 企業プロファイル
    • electroCore, Inc.
    • LivaNova, PLC
    • SetPoint Medical Corporation
    • MicroTransponder, Inc.
    • Beijing PINS Medical Co., Ltd.
    • Parasym Ltd.
    • Nervana, LLC.
    • tVNS Technologies GmbH

第9章 セクション

  • 参考文献
  • 調査方法
  • Coherent Market Insightsについて
目次

Vagus nerve stimulation (VNS) is a U.S. Food and Drug Administration (FDA) approved therapy, which involves stimulation of vagus nerve with the help of stimulator that provides electric impulses to vagus nerve. Vagus nerve stimulator is widely used in the treatment of epilepsy, depression, cluster headache, migraine, asthma, bronchoconstriction, exercise-induced bronchospasm, chronic obstructive pulmonary disease (COPD), gastric motility disorder, and irritable bowel syndrome. Currently, there are two types of vagus nerve stimulator present in the market- implantable vagus nerve device and external vagus nerve device. Implantable devices are implanted inside the body surgically. However, the external devices are nob-invasive and are used outside the body

Market Dynamics

High prevalence of depression epilepsy and migraine in key regions is expected to drastically rise demand for vagus nerve stimulators for its treatment. For instance, according to the data published by the Centers for Disease Control and Prevention in 2015, around 3 million U.S. adults and 470,000 children had active epilepsy (under treatment or with recent seizures). The number of adults with active epilepsy increased from 2.3 million in 2010 to 3 million in 2015.

According to the data published by National Institute of Mental Health in 2016, an estimated 16.2 million adults in the U.S. had at least one major depressive episode. This number represented 6.7% of all U.S. adults. According to the same source the prevalence of major depressive episode was higher among adult females (8.5%) compared to males (4.8%) and the prevalence of adults with a major depressive episode was highest among individuals aged 18-25 (10.9%).

Approval and launch of novel products in market is also expected to support the vagus nerve stimulators market growth over the forecast period. For instance, in June 2017, electroCore, Inc. received the U.S. Food and Drug Administration (FDA) 510(k) clearance to market a newer version of gammaCore (non-invasive vagus nerve stimulator) - the gammaCore-S - for acute treatment of pain associated with episodic cluster headache (eCH) in adult patients.

Furthermore, in February 2019, the U.S. Centers for Medicare & Medicaid Services (CMS) finalized its national coverage determination (NCD) for the LivaNova Plc.'s vagus nerve stimulation therapy (VNS Therapy) System for treatment-resistant depression (TRD). Such favorable reimbursements for VNS devices for depression treatment is also expected to increase its adoption and drive vagus nerve stimulators market growth

Key features of the study:

  • This report provides in-depth analysis of global vagus nerve stimulators market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global vagus nerve stimulators market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include electroCore, Inc., LivaNova, PLC, SetPoint Medical Corporation, MicroTransponder, Inc., Beijing PINS Medical Co., Ltd., Parasym Ltd., Nervana, LLC., and tVNS Technologies GmbH
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global vagus nerve stimulators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the vagus nerve stimulators market

Detailed Segmentation:

  • Global Vagus Nerve Stimulators Market, By Product Type:
    • Implantable Devices
    • External Devices
  • Global Vagus Nerve Stimulators Market, By Application:
    • Epilepsy
    • Depression
    • Cluster Headache & Migraine
    • Others
  • Global Vagus Nerve Stimulators market, By Distribution Channel:
    • Hospital
    • Specialty Pharmacy
    • Others
  • Global Vagus Nerve Stimulators Market, By Geography:
    • North America
      • By Product Type :
      • Implantable Devices
      • External Devices
      • By Application:
      • Epilepsy
      • Depression
      • Cluster Headache & Migraine
      • Others
      • By Distribution Channel
      • Hospital
      • Specialty Pharmacy
      • Others
      • By Country:
      • U.S.
      • Canada
    • Europe
      • By Product Type :
      • Implantable Devices
      • External Devices
      • By Application:
      • Epilepsy
      • Depression
      • Cluster Headache & Migraine
      • Others
      • By Distribution Channel
      • Hospital
      • Specialty Pharmacy
      • Others
      • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type :
      • Implantable Devices
      • External Devices
      • By Application:
      • Epilepsy
      • Depression
      • Cluster Headache & Migraine
      • Others
      • By Distribution Channel
      • Hospital
      • Specialty Pharmacy
      • Others
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • By Product Type :
      • Implantable Devices
      • External Devices
      • By Application:
      • Epilepsy
      • Depression
      • Cluster Headache & Migraine
      • Others
      • By Distribution Channel
      • Hospital
      • Specialty Pharmacy
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East
      • By Product Type :
      • Implantable Devices
      • External Devices
      • By Application:
      • Epilepsy
      • Depression
      • Cluster Headache & Migraine
      • Others
      • By Distribution Channel
      • Hospital
      • Specialty Pharmacy
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type :
      • Implantable Devices
      • External Devices
      • By Application:
      • Epilepsy
      • Depression
      • Cluster Headache & Migraine
      • Others
      • By Distribution Channel
      • Hospital
      • Specialty Pharmacy
      • Others
      • By Country:
      • Central Africa
      • South Africa
      • North Africa
  • Company Profiles
    • electroCore, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • LivaNova, PLC
    • SetPoint Medical Corporation
    • MicroTransponder, Inc.
    • Beijing PINS Medical Co., Ltd.
    • Parasym Ltd.
    • Nervana, LLC.
    • tVNS Technologies GmbH
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Novel Product Launch/Approval
    • PEST Analysis
    • Porter's Analysis
    • Reimbursement Scenario

4. Global Vagus Nerve Stimulators Market, By Product Type, 2018 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Implantable Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • External Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Vagus Nerve Stimulators Market, By Application, 2018 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Epilepsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Cluster Headache & Migraine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Vagus Nerve Stimulators Market, By Distribution Channel, 2018 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Specialty Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Vagus Nerve Stimulators Market, By Region, 2018 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
    • North America
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
    • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
    • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
    • electroCore, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • LivaNova, PLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • SetPoint Medical Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • MicroTransponder, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Beijing PINS Medical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Parasym Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Nervana, LLC.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • tVNS Technologies GmbH
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Back to Top